Inhibitor Therapeutics, Inc.
INTI · OTC
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Assets | – | – | – | – |
| Cash & Equivalents | $2,977 | $3,738 | $4,322 | $5,607 |
| Short-Term Investments | $0 | $0 | $0 | $0 |
| Receivables | $0 | $0 | $0 | $0 |
| Inventory | $0 | $0 | $0 | $0 |
| Other Curr. Assets | $87 | $92 | $99 | $88 |
| Total Curr. Assets | $3,064 | $3,830 | $4,421 | $5,695 |
| Property Plant & Equip (Net) | $71 | $78 | $84 | $0 |
| Goodwill | $0 | $0 | $0 | $0 |
| Intangibles | $0 | $0 | $0 | $0 |
| Long-Term Investments | $0 | $0 | $0 | $0 |
| Tax Assets | $0 | $0 | $0 | $0 |
| Other NC Assets | $0 | $0 | $0 | $0 |
| Total NC Assets | $71 | $78 | $84 | $0 |
| Other Assets | $0 | $0 | $0 | $0 |
| Total Assets | $3,135 | $3,908 | $4,505 | $5,695 |
| Liabilities | – | – | – | – |
| Payables | $20 | $106 | $37 | $16 |
| Short-Term Debt | $27 | $26 | $26 | $0 |
| Tax Payable | $0 | $0 | $0 | $0 |
| Deferred Revenue | $3,000 | $0 | $0 | $0 |
| Other Curr. Liab. | -$2,960 | -$26 | -$26 | $0 |
| Total Curr. Liab. | $88 | $140 | $95 | $710 |
| LT Debt | $44 | $0 | $0 | $0 |
| Deferred Rev, NC | $0 | $3,000 | $3,000 | $3,000 |
| Deferred Tax Liab, NC | $0 | $0 | $0 | $0 |
| Other NC Liab. | $3,000 | $0 | $0 | $0 |
| Total NC Liab. | $3,044 | $3,052 | $3,058 | $3,000 |
| Other Liabilities | $0 | $0 | $0 | $0 |
| Cap. Leases | $72 | $78 | $84 | $0 |
| Total Liabilities | $3,132 | $3,192 | $3,153 | $3,710 |
| Equity | – | – | – | – |
| Pref Stock | $0 | $0 | $0 | $0 |
| Common Stock | $17 | $17 | $17 | $17 |
| Retained Earnings | -$54,124 | -$53,412 | -$52,752 | -$52,119 |
| AOCI | $0 | $0 | $0 | $0 |
| Other Equity | $54,110 | $0 | $0 | $0 |
| Total Equity | $3 | $716 | $1,352 | $1,985 |
| Supplemental Information | – | – | – | – |
| Minority Interest | $0 | $0 | $0 | $0 |
| Total Liab. & Tot. Equity | $3,135 | $3,908 | $4,505 | $5,695 |
| Net Debt | -$2,905 | -$3,712 | -$4,296 | -$5,607 |